NCT05092503View on ClinicalTrials.gov

JINZHEN for Treatment of Mild to Moderate COVID-19

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 26, 2022

Primary Completion Date

May 12, 2023

Study Completion Date

May 12, 2023

Conditions
COVID-19
Interventions
DRUG

JINZHEN Granules for Oral Solution

JINZHEN granules will be dissolved in drinking water and administered orally.

DRUG

Placebo

Placebo granules will be dissolved in drinking water and administered orally.

Trial Locations (10)

15478

Frontier Clinical Research LLC, Smithfield

26505

Frontier Clinical Research LLC, Morgantown

28303

Carolina Institute for Clinical Research, Fayetteville

29707

Piedmont Research Partners, Fort Mill

33016

Family First Medical Research Center, Hialeah Gardens

LMG Research, Miami

48504

AA Medical Research Center, Flint

75149

SMS Clinical Research, Mesquite

91351

Clearview Medical Research LLC, Canyon Country

07002

F. Gabriel LLC, Bayonne

All Listed Sponsors
lead

Lianyungang Kanion Group, Ltd.

INDUSTRY